Volume 31 (2024)
Volume 30 (2023)
Volume 29 (2022)
Volume 28 (2021)
Volume 27 (2020)
Volume 26 (2019)
Volume 25 (2018-2019)
Volume 24 (2017-2018)
Volume 23 (2016-2017)
Volume 22 (2015-2016)
Volume 21 (2014-2015)
Volume 20 (2013-2014)
Volume 19 (2012-2013)
Volume 18 (2011-2012)
Volume 17 (2010-2011)
Volume 16 (2009-2010)
Volume 15 (2008-2009)
Volume 14 (2007-2008)
Volume 13 (2006-2007)
Volume 12 (2005-2006)
Volume 11 (2004-2005)
INCREASED SOLUBLE FAS SERUM LEVELS AND ITS RELATIONSHIP WITH THYROID AUTOANTIBODY POSITIVITY IN UNTREATED GRAVES HYPERTHYROIDISM IN TEHRAN, IRAN

N SEDDIGHI; MB ARDESHIR LARIJANI; S SHARGHI; R HESHMAT; P SHOUSHTARIZADEH; V HAGHPANAH; B RAJABI POUR; A LASHKARI

Volume 13, Issue 3 , September and October 2006, , Pages 116-121

Abstract
  Background and Purpose: Serum soluble Fas (sFas) is found in low concentrations in the sera of healthy subjects and it elevated in patients with autoimmune diseases, malignancy and inflammatory diseases. The Fas molecules play some role in the pathogenesis of Graves’ disease through interfering with ...  Read More

DIAGNOSIS OF PENDRED SYNDROME: MRI VERSUS OTHER TRADITIONAL CRITERIA

MB ARDESHIR LARIJANI; M MOTASADDI; H HADIZADEH; A FARD ESFAHANIAN; R HESHMAT; O TABATABAEI; S SHARGHI; V HAGHPANAH; E TAHERI; A LASHKARI

Volume 13, Issue 1 , March and April 2006, , Pages 33-39

Abstract
  Background and purpose: Pendred syndrome, defined traditionally as the constellation of goiter, sensori-neural hearing loss and positive perchlorate discharge test. Since the relatively newer approaches to the diagnosis of this syndrome, as MRI and genetic and/or molecular analysis are much more expensive ...  Read More